{"entity":{"id":"nct03322995","kind":"trial","name":"Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial","aka":["PANC"],"tldr":"A phase 2 trial in pancreatic cancer, run by Medical College of Wisconsin, now recruiting.","summary":"Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial is a phase 2, interventional study registered as NCT03322995 by Medical College of Wisconsin, with a registry enrolment figure of 125 participants, started 2018-06-21 and due to reach its primary completion in 2027-06-01. Interventions recorded: First-line Chemotherapy; Second-line Chemotherapy; Chemoradiation. Conditions listed: Pancreatic Cancer. Primary outcome: Completion of all intended neoadjuvant therapy and surgical therapy. Pancreatic eligibility wording from the registry: \"* Have clinical stage consistent with resectable or borderline resectable adenocarcinoma of the pancreas, based on CT or MRI findings\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT03322995","url":"https://clinicaltrials.gov/study/NCT03322995"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["borderline-resectable-pdac","resectable-pdac"],"sections":[],"technologies":["imrt-igrt"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03322995","phase":"2","setting":"Adaptive Modification of Neoadjuvant Therapy Based on Clinical Response in Patients With Localized Pancreatic Cancer","sponsor":"Medical College of Wisconsin","enrolled":125,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03322995/","neighbours":{"cancer":[{"id":"borderline-resectable-pdac","kind":"cancer","name":"Borderline resectable pancreatic ductal adenocarcinoma","route":"/cancers/borderline-resectable-pdac/"},{"id":"resectable-pdac","kind":"cancer","name":"Resectable pancreatic ductal adenocarcinoma","route":"/cancers/resectable-pdac/"}],"technology":[{"id":"imrt-igrt","kind":"technology","name":"IMRT / IGRT (modern external beam)","route":"/technologies/imrt-igrt/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}